Robert C. Griggs MD, FAAN

University of Rochester

Dr. Griggs is Professor of Neurology, Medicine, Pathology and Laboratory Medicine, Pediatrics and the Center for Health and Technology at the University of Rochester School of Medicine and Dentistry. He was Chair of the Department of Neurology and Neurologist-in-Chief at Strong Memorial Hospital (1986-2008). He received his BA from the University of Delaware and his M.D. from the University of Pennsylvania. He received training in Internal Medicine at Case Western Reserve University and the University of Rochester where he was Chief Resident in Medicine and Fellow in Immunology. He trained in Neurology at the National Institute of Neurological Disorders and Stroke (NINDS) and the University of Rochester where he was Chief Resident in Neurology. Dr. Griggs is an internist/neurologist specializing in neuromuscular diseases with a focus on experimental therapeutics. He has directed an NIH-funded training program in the Experimental Therapeutics of Neurological Disease since 1989 (refunded through 2020). This program has trained over 80 clinical neuroscientists who are in academic and other leadership positions around the world. He has published over 400 scientific papers and 26 texts which span the fields of medicine and neurology. He is an Editor of Cecil Textbook of Medicine and of Cecil Essentials of Medicine. He was elected to the National Academy of Medicine in 1998. He was Editor-in-Chief of Neurology 1996-2006 and President (2009-2011) of the American Academy of Neurology. In 1998, Dr. Griggs established the Muscle Study Group (MSG), an international consortium of investigators focused on developing new treatments for neuromuscular disease. Dr. Griggs is the principal investigator of an international, NIH-funded clinical trial to define the optimum corticosteroid regimen for Duchenne muscular dystrophy. His FDA and NIH-funded studies of periodic paralysis showed the benefit of dichlorphenamide, now the first FDA-approved treatment for periodic paralysis. Dr. Griggs chairs the Research Advisory Committee of the American Brain Foundation (ABF). The ABF funds research to develop new treatments and supports and fosters the careers young clinical neuroscientists.